AID Cann
Formerly D-Pharm, Univo
Medical Cannabis Products
Startup Public Health Tech & Life Sciences Est. 1993
Total Raised
$37.65M
Public
Last Round
$3.6M
5 rounds
Investors
11
11 public
Team
3
11-50 employees
Confidence
90/100
News
15
articles
Patents
1
About
AID Cann is a vertically integrated medical cannabis company focused on the cultivation, manufacture, distribution, and creation of products and dosage forms for medical cannabis products. The company holds initial licenses for the entire supply chain, including growing, breeding, and nursery; production of medical cannabis products; research and development; and distribution. The company produces its own cannabis by way of a partnership with Amit Farms, which is located in the south of Israel and designated for cannabis growth. The farm uses innovative agricultural technologies to grow high-quality cannabis and to develop Univos strains designed to meet specific therapeutic needs. AID Cann manufacturing facility produces a wide variety of medical cannabis products that meet the most stringent international standards. The plant is IMC-GMP certified and began production in Q3 2019. The company uses ethanol and CO2-based extraction technologies to manufacture a wide range of medical cannabis products. Additional technologies will be added to enable different delivery systems and dosages to meet the needs of the products in its R&D pipeline.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisAgriculture & Food TechnologiesAg TechFarm Equipment & Treatment
Target Customer
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business Model
B2B2C
Tags
pharmaceuticalsdegenerative-diseasesepilepsyneurologyagtechmedical-cannabisbreeding
Funding & Events
Sep 2018
Exit Undisclosed
Sep 2009
Exit Undisclosed
Oct 2001
D Round $30M
Quintiles, Rho Ventures, Coven Group, Morgan Stanley Venture Partners, Care Capital, SGVC, Clal Biotechnology Industries (CBI)
Jun 2021
M&A $1.7M
Jul 2021
PIPE $3.6M
Nir Tzuk
Jul 2019
PIPE $846K
Chaim Hurvitz, Ido Hagag
Jan 2015
PIPE $3.2M
Undisclosed Investor(s), Clal Biotechnology Industries (CBI)
Dec 2024
Exit Undisclosed
News (15)
Nov 4, 2021 · www.calcalist.co.il
growth-positive
יוניבו תספק קנאביס רפואי למטופלי הכללית בחוזה של "מיליוני שקלים בשנה" כלכליסט
Customers
Jul 28, 2021 · www.globes.co.il
growth-positive
צעצוע של עשירים: ניר צוק משקיע בחברת הקנאביס יוניבו
Investment
Jun 14, 2021 · www.jpost.com
growth-positive
https://www.jpost.com/health-science/israeli-medical-cannabis-firm-univo-acquires-pharmacy-medipharm-671013
CustomersPartners
Jun 9, 2021 · www.businesswire.com
growth-positive
Fluence Expands Footprint in Burgeoning Israeli Cannabis Industry, Supports Multiple Cultivators Through REMY Partnership
PartnersExpand
May 10, 2021 · www.globenewswire.com
growth-positive
DNA Genetics Announces Strategic Alliance Agreement With Vertically-Integrated Israeli Cannabis Company, UNIVO Pharmaceuticals
Partners
Oct 27, 2020 · www.benzinga.com
growth-positive
Israeli Cannabis Co. Univo Will Enter The U.K. Market - Benzinga
Partners
Jun 24, 2020 · en.globes.co.il
growth-positive
Univo importing cannabis to Israel from Lesotho, Canada
PartnersCustomers
Mar 1, 2020 · en.globes.co.il
growth-positive
Univo teams with Canada's Canopy on medical cannabis
PartnersCustomers
Jan 16, 2020 · www.businesswire.com
Can-Fite and Univo Pharmaceuticals Collaboration Result in Discovery and Applied Patent for Cannabinoid Formulations with Broad Therapeutic Effects
Oct 31, 2019 · en.globes.co.il
growth-positive
Cannabis co Univo raises NIS 12m from Avisror Group
Investment
Oct 29, 2019 · en.globes.co.il
growth-positive
Univo medical cannabis approved for pharmacy sales
CustomersPartners
Jul 24, 2019 · en.globes.co.il
growth-negative
Hagag, Hurvitz investing NIS 3m more in Univo
Investment
Apr 3, 2019 · en.globes.co.il
growth-positive
Ehud Olmert joins Israeli cannabis co Univo
Investment
Sep 13, 2018 · en.globes.co.il
growth-positive
UNV signs new deal with Israeli cannabis startup
PartnersAcquisition
Apr 15, 2015 · www.globes.co.il
growth-positive
Chinese regulator approves D-Pharm epilepsy drug trial
Partners
Details
Product Stage
Released
Employees
11-50
Exact Count
13
District
Center District
Founded
1993
Registrar
511799835
Crunchbase
d-pharm-ltd
Locations
HaArba'a Street 30, Tel Aviv-Yafo, Israel
Links
Website
LinkedIn
Admin
Last Update
Mar 3, 2025
Verified by
Yanina Wainscheinker
Missing
markets, not claimed
Team (3)
Nir Ben Zvi
Founder & Board Member
Founder
Alexander Kozak, Dr.
Founder
Founder
Golan Bitton
Co-founder & (Left the company)
Founder
Internal
Created by
Sharon Shapira (shapira.sharon2@gmail.com)
Created
2014-11-12T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)
Status
Acquired by Limited 1498 on Dec, 2024